Mark Warner is not dominating the news cycle right now. Three posts on Bluesky in the last 24 hours, zero Google News hits, and the most exciting thing anyone said about him online was a list of Democrats who apparently 'think it's great', whatever 'it' is. The Senator from Virginia is quiet. His brokerage account was not. Fifteen disclosed trades in the last 90 days, all clustered in two early-April windows, spanning banks, big tech, private equity, software, and a chocolate company. Warner sits on the Senate Banking Committee, the Finance Committee, and the Senate Select Committee on Intelligence. That's a lot of oversight jurisdiction for a portfolio this active.
The Burst
Warner filed 15 trades between April 6 and April 13, nine purchases and three sales on April 13 alone, plus two Amgen sales on April 6 and 7, and a Hershey buy and an iShares Russell 1000 Growth purchase on April 8. That's a week of concentrated activity.
April 13, in particular, reads like someone sat down with a shopping list. He bought Wells Fargo, Microsoft, Blackstone, Rocket Companies, Toast, Atlassian, Accenture, and Constellation Energy, all in the $1,000-$15,000 range, and simultaneously sold out of three ETF positions: iShares Russell 1000 Growth (IWF), iShares Russell 1000 Value (IWD), and Vanguard Growth ETF (VUG).
The read: he swapped broad index exposure for individual stock picks. Whether that was savvy is a different question. The alpha record answers it, and not favorably.
The Scorecard
Across 30 scored trades, Warner's portfolio is 13 positive and 17 negative against the S&P 500, with a mean 30-day alpha of negative 1.5 percent. That's slightly worse than just buying an index fund and going to committee hearings instead.
The outlier in the other direction: his April 13 purchase of Atlassian (TEAM) returned 47.3% in alpha terms over 30 days. That's the best single trade in the scored sample by a wide margin, and it has no committee overlap listed. Atlassian makes project management software. Warner's committees cover banking, finance, and intelligence. The Venn diagram of Senate Banking oversight and Atlassian's business is empty. So it's a trade that worked, and nothing more needs to be said about it.
Rocket Companies, also bought April 13, returned 8.5% alpha. No committee overlap there either. A mortgage tech company bouncing in a volatile rate environment.
The worst trades in the sample are a different story.
The Amgen Problem
On April 6 and again on April 7, Warner sold Amgen (AMGN). Both sales are flagged in the data with a committee overlap note: Biotechnology. Warner's Finance Committee assignments include Health Care. Amgen is a large biotech company whose drug pricing and Medicare reimbursement exposure sit squarely in the Finance Committee's lane.
He sold April 6. Alpha over the following 30 days: negative 14.4%. He sold April 7. Alpha: negative 12.9%.
He sold, and then the stock went down. The sales looked bad relative to the market. He got out before a decline that, from a pure performance standpoint, validated the exit, except the alpha metric shows his sales underperformed the S&P on a relative basis, meaning the stock dropped but the market dropped more, or the timing was off enough that the comparison doesn't flatter him. The numbers say what they say: two committee-overlapping sales, both in the negative column for alpha.
Members are required to disclose. They are not required to divest, recuse, abstain, blush, or look up from their phones.
The Banking Committee Trades
Warner's committee overlap trades include two bank stocks: Fifth Third Bancorp (FITB), purchased March 20, and Wells Fargo (WFC), purchased April 13. Both fall under the Senate Banking Committee's direct remit. That's the committee Warner actually sits on, the one that writes the rules banks have to follow.
Fifth Third returned 7.8% alpha over 30 days. That's the better of the two.
Wells Fargo returned negative 8.7% alpha. He bought Wells Fargo on April 13 and it went the wrong way relative to the market over the next month. So if you were hoping the Banking Committee seat was producing consistent alpha on bank stocks, the data says no.
The full committee overlap portfolio, FITB, Microsoft, Apple, Wells Fargo, and the two Amgen sales, is a mixed bag. One solid winner in Fifth Third, one decent tech buy in Microsoft (plus 6.3% alpha), a modest Apple return (plus 2.8%), and two duds in Wells Fargo and Amgen. That's three of five committee-overlap trades in positive territory, but the negative ones drag hard enough that 'conflict of interest as alpha generator' is not the story the numbers tell.
The Floor Votes
Warner's recent floor activity has been busy but largely outside his committee wheelhouse. He voted yes on the 21st Century ROAD to Housing Act, three separate votes between June 16 and June 22 as the bill moved through cloture and final passage. He voted yes on bipartisan war-powers resolutions trying to pull U.S. Forces out of hostilities with Iran, including a concurrent resolution that actually passed on June 23. He voted no on proceeding to the Fallen Servicemembers Religious Heritage Restoration Act on June 5.
The housing bill carries a market-relevance score in the data, and Warner did hold Rocket Companies, a mortgage origination platform, purchased on April 13. The ROAD to Housing Act is broadly aimed at increasing housing supply. Rocket Companies operates in the mortgage origination space. That's a proximity worth noting, not a conclusion worth drawing.
The Iran war-powers votes are a different animal entirely. Warner's Intel Committee seat is directly relevant to Iran policy. His trading record around those votes shows nothing flagged. No overlap, no timing note. The votes are just votes.
The Portfolio as Character Study
Zooming out: the April 13 buy list is an interesting window into what a senior Democrat on the Banking, Finance, and Intelligence committees thinks is worth owning during a volatile market moment.
He bought Wells Fargo and Blackstone, traditional finance. He bought Microsoft and Atlassian, software and cloud. He bought Constellation Energy, nuclear power. He bought Accenture, consulting. He bought Toast, restaurant tech. He bought Rocket Companies, mortgage origination. And he offloaded his broad ETF exposure to do it.
Constellation Energy ($CEG) is worth a line. The company operates nuclear plants and has been central to the AI data center power story, given the grid demands of large language model infrastructure. Warner's Intelligence Committee work touches on AI and national security. His Finance Committee work touches on energy tax credits. CEG sits at an intersection of both. The alpha on that trade is not in the scored sample provided, so the performance call is unanswered. The position itself is the note.
The Hershey buy on April 8 is the one that earns a raised eyebrow just for existing. Hershey makes chocolate. Warner's committees cover banking, finance, intelligence, and tax policy. The Venn diagram of Senate oversight jurisdiction and cocoa futures is, again, two non-overlapping circles. It's a consumer staples buy during a market selloff. Maybe the Senator just thinks chocolate is recession-proof. He's not wrong historically.
The Bottom Line on Alpha
Thirteen wins out of 30 scored trades, mean alpha of negative 1.5%. That's the full honest sample, not a highlight reel. The 47.3% Atlassian trade is real, the negative 20.1% LNG sale is also real (sold Cheniere Energy in March; the stock subsequently ran). The record has peaks and craters in roughly equal measure, with the craters winning on count (17 negative versus 13 positive).
What the committee overlap trades show is not a pattern of consistent outperformance in sectors where Warner has oversight power. What they show is a senator who trades stocks in sectors he oversees, sometimes well and sometimes badly, with the full range of outcomes you'd expect from an active individual investor.
The receipts are public. Make of them what you make of them.